share_log

シンバイオ製薬---東和薬品に対する特許権侵害に基づく東和製品の製造販売の差止及び損害賠償請求について和解成立

Settlement reached concerning the injunction and damages claim for manufacturing and selling East Pharmaceutical products based on patent infringement against Shin Bio Pharmaceutical---Toa Pharmaceutical.

Fisco Japan ·  Sep 30 22:00

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment